The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A novel prognostic model to optimize the timing of docetaxel (Doc) following an androgen receptor pathway inhibitor (ARPi) in metastasic castration-resistant prostate cancer (mCRPC).
 
Lola Rodríguez Nogueira
No Relationships to Disclose
 
Rodrigo España
No Relationships to Disclose
 
Maria Ruiz Vico
No Relationships to Disclose
 
Jorge Esteban Villarrubia
No Relationships to Disclose
 
Casilda Llácer
Honoraria - Roche
Travel, Accommodations, Expenses - Astellas Amgen BioPharama
 
Rebeca Lozano
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen; Roche; Sanofi
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Janssen Oncology; Merck/Pfizer; Orion
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb/Pfizer; Ipsen; Janssen; Merck; MSD; Roche; Sanofi
 
Nuria Romero-Laorden
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Janssen; MSD
Research Funding - Janssen-Cilag (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Guillermo de Velasco
Honoraria - Astellas Pharma; BMS; Ipsen; Pfizer
Consulting or Advisory Role - Astellas Medivation; Bayer; Bristol-Myers Squibb; Ipsen; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Pierre Fabre; Roche
Research Funding - Ipsen
Travel, Accommodations, Expenses - BMS; BMS; Roche
 
Rosa Villatoro
No Relationships to Disclose
 
Lucía García
No Relationships to Disclose
 
Pablo Alvarez-Ballesteros
No Relationships to Disclose
 
David Hernández
No Relationships to Disclose
 
Alfredo Rodríguez Antolín
No Relationships to Disclose
 
Enrique Gonzalez-Billalabeitia
Consulting or Advisory Role - AstraZeneca; Bayer; Janssen Oncology
Research Funding - AstraZeneca; Merck
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen-Cilag; Pfizer; Pfizer; Roche; Sanofi
 
Bernardo Herrera Imbroda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Johnson & Johnson/Janssen; Recordati
Speakers' Bureau - Astellas Pharma; Johnson & Johnson/Janssen
Research Funding - Johnson & Johnson/Janssen (Inst)
 
Daniel Castellano
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Novartis; Pfizer; Roche
 
Elena Castro
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag; MSD Oncology; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Daiichi Sankyo Europe GmbH; Janssen; Lilly; Merck; MSD Oncology; Pfizer
Speakers' Bureau - AstraZeneca; Janssen; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Janssen (Inst); Pfizer (Inst)
Expert Testimony - Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Janssen; Pfizer
 
David Lorente
No Relationships to Disclose
 
David Olmos
Stock and Other Ownership Interests - VDG diagnostics
Honoraria - Bayer; Janssen
Consulting or Advisory Role - AstraZeneca; Bayer; Janssen; MSD Oncology; Pfizer
Research Funding - Johnson & Johnson/Janssen (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Bayer; Janssen